Thiago Pimentel Muniz

Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition

Aljosja Rogiers, Inês Pires da Silva, Chiara Tentori et al. · Journal for ImmunoTherapy of Cancer · 2021 · 59 citations · Full text

Biologic subtypes of melanoma predict survival benefit of combination anti-PD1+anti-CTLA4 immune checkpoint inhibitors versus anti-PD1 monotherapy

April A. N. Rose, Susan Armstrong, David Hogg et al. · Journal for ImmunoTherapy of Cancer · 2021 · 49 citations · Full text

Retrospective comparison of the efficacy and the toxicity of standard and modified FOLFIRINOX regimens in patients with metastatic pancreatic adenocarcinoma

Victor Hugo Fonseca de Jesus, Marcos Pedro Guedes Camandaroba, Mauro Daniel Spina Donadio et al. · Journal of Gastrointestinal Oncology · 2018 · 35 citations · Full text

First-in-class microbial ecosystem therapeutics 4 (MET4) in metastatic solid cancer patients treated with immunotherapy: MET4-IO.

Daniel Vilarim Araújo, M. Oliva Bernal, Tira J. Tan et al. · Journal of Clinical Oncology · 2020 · 28 citations

Real World Outcomes and Hepatotoxicity of Infliximab in the Treatment of Steroid-Refractory Immune-Related Adverse Events

Daniel Vilarim Araújo, Thiago Pimentel Muniz, Anjie Yang et al. · Current Oncology · 2021 · 24 citations · Full text